Lisata Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $100 | $0 |
Gross Profit | -3 | -2 | 100 | |
EBITDA | -3,989 | -4,874 | -2,939 | -4,205 |
EBIT | -3,992 | -4,876 | -2,954 | -4,249 |
Net Income | -2,929 | -4,489 | -2,954 | -4,249 |
Net Change In Cash | 0 | 0 | 100 | 0 |
Free Cash Flow | -2,649 | -3,083 | -3,249 | -3,342 |
Cash | 10,443 | 13,060 | 15,956 | 18,998 |
Basic Shares | 9,106 | 9,006 | 8,687 | 8,738 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $170 | $1,000 | $0 | $121,372 |
Gross Profit | 24 | 1,000 | -189 | 63,771 |
EBITDA | -17,402 | -20,609 | -22,981 | -56,635 |
EBIT | -17,548 | -20,783 | -23,170 | -56,704 |
Net Income | -16,586 | -19,985 | -20,840 | -54,225 |
Net Change In Cash | 170 | 1,000 | 0 | 121,372 |
Free Cash Flow | -15,977 | -19,356 | -20,032 | -21,455 |
Cash | 15,956 | 16,209 | 22,593 | 32,154 |
Basic Shares | 8,687 | 8,329 | 8,073 | 5,180 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.54 |
2026-03-31 | -$0.33 |
2025-12-31 | -$0.33 |
2025-09-30 | -$0.49 |